Vice President Joe Biden is leading a new national initiative, Cancer Moonshot, to accelerate cancer research and ultimately eliminate cancer as we know it. This initiative has just received a boost from the creation of a new data-sharing network, called Oncology Precision Network (OPeN). OPeN will provide access to precision medicine and clinical trials for previously underserved cancer patients.
Vice President Joe Biden highlighted this initiative in his introductory comments at the Cancer Moonshot Summit that took place in Washington, DC on June 29. In conjunction, the White House released a related Fact Sheet that states:
“Intermountain Healthcare, Stanford Cancer Institute, Providence Health & Services, Catholic Health Initiative, Henry Ford Health System, and Syapse have joined together to launch OPeN, the Oncology Precision Network. OPeN will advance cancer care through sharing of cancer genomics data, rapidly bringing the most promising treatment insights to cancer patients and physicians with the potential of increasing access to clinical trials. With its current membership, OPeN comprises data and physicians across 11 states, 79 hospitals and 800 clinics, and will impact 50,000 new cancer cases per year.”
Several representatives of OPeN participated in the Cancer Moonshot Summit, including Lincoln Nadauld, MD, PhD, who is the Director of Cancer Genomics at Intermountain Health Care, an Adjunct Professor of Oncology at Stanford School of Medicine, and a Scientific and Medical Advisor at TOMA Biosciences.
Photo by Marc Nozell